Devanshu Patel

Devanshu Patel

Active Director Director DIN 09151069
DIN 09151069 First appointment Apr 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Devanshu Patel

Data last updated:

Devanshu Patel is a Director at Zeal Medical Private Limited (since 2021). The company operates in Healthcare. Zeal Medical Private Limited reported revenue of ₹25.42 Cr (FY 2024).

DIN 09151069
Primary Designation Director
Industry Healthcare
First Appointment 20 Apr 2021
Oldest Company Age 28 yrs
Largest company Zeal Medical Private Limited · ₹25.42 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zeal Medical Private Limited U33100MH1997PTC111733
Director20 Apr 20211997₹25.42 Cr (FY 2024)Active

Board colleagues of Devanshu Patel

Directorship timeline

Open interactive timeline →
Zeal Medical Private Limited
Premium access

Shareholding and investment profile for Devanshu Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devanshu Patel

Devanshu Patel currently holds 1 directorship: Zeal Medical Private Limited (Director, since 20 Apr 2021, revenue ₹25.42 Cr (FY 2024)).

Devanshu Patel was first appointed on 20 Apr 2021 as Director at Zeal Medical Private Limited.

The current boards of Devanshu Patel's companies include Bhavna Shailesh Patel (Zeal Medical Private Limited), Shailesh Harilal Patel (Zeal Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available